Colberg to step down as Evonik CFO

The executive committee of Evonik Industries has asked its supervisory board to approve the termination of Wolfgang Colberg as the company’s CFO

The executive committee of Germany based Evonik Industries has asked its supervisory board to approve the termination of Wolfgang Colberg as the company’s Chief Financial Officer, effective 30 September. The proposal, said to be the result of a “mutual agreement” between the two parties, will see Colberg step down after serving as CFO of Evonik since 2009.

The board has nominated Ute Wolf as Colberg’s successor with effect from 1 October. Wolf has been head of finance at Evonik since 2006.

The final decision is to be made by the supervisory board by 21 June.

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Future beauty forecasting from in-cosmetics Global 2024

Longevity, pre-ageing and AI-empowered ingredients were some standout themes from the Paris ingredients trade show last week
Ingredients

Evonik establishes new naturals business segment

The Botanicals & Natural Actives segment falls under the German specialty chemicals giant’s life sciences division
Manufacturing

Evonik boosts active ingredients portfolio with Novachem acquisition

Novachem specialises in creating eco-certified actives from live microorganisms
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

in-cosmetics Global: 2023’s top beauty ingredient trends

Senescence busters, mood hacking beauty and naturally-derived, high-performance materials lead this year’s batch of cosmetic ingredient launches
Ingredients

Beiersdorf and WWF extend sustainable palm oil cooperation until 2026

Ingredients supplier Evonik will also be onboarded as a new partner for the project
Manufacturing

Evonik kickstarts full commercial-scale ceramides production

Evonik’s decision to upscale its ceramides production follows on from a strong Q3 2022 sales
Ingredients

Cosmetic ingredients boost Evonik’s Q3 Nutrition & Care sales

The division’s sales increased 14% due to price increases, but its EBITDA fell by 23%
Subscribe now